Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


Connect
FCPA Blog Daily News

Entries in TAP Pharmaceutical Products Inc. (1)

Tuesday
Feb182014

Parental controls: anti-corruption compliance programs for joint ventures, subsidiaries and franchisees (Part 1)

Due to the strict liability approach governing the FCPA’s accounting provisions, public companies generally include majority-owned subsidiaries in their anti-corruption compliance programs. But what is the best compliance governance approach for other "parent-child” contexts?

Click to read more ...